# A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and Panitumumab

> **NCT05993455** · PHASE2 · UNKNOWN · sponsor: **Korea University Anam Hospital** · enrollment: 24 (estimated)

## Conditions studied

- Efficacy

## Interventions

- **DRUG:** Oral sotorasib + IV Panitumumab

## Key facts

- **NCT ID:** NCT05993455
- **Lead sponsor:** Korea University Anam Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-03
- **Primary completion:** 2023-09-04
- **Final completion:** 2023-12-31
- **Target enrollment:** 24 (ESTIMATED)
- **Last updated:** 2023-08-15


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05993455

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05993455, "A Phase 2 Basket Trial in Which Patients With Advanced Solid Tumors Carrying the KRAS G12C mUtation Receive Treatment With a Combination of Sotorasib and Panitumumab". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT05993455. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*